<?xml version="1.0"?>
<body status="ih"><p nid="t0:ih:1">HR 99 IH</p><p/><center><p nid="t0:ih:2">113th CONGRESS</p></center>
<p/><center><p nid="t0:ih:3">1st Session</p></center>
<p/><center><p nid="t0:ih:4">H. R. 99</p></center>
<p nid="t0:ih:5">To prohibit anticompetitive activities and to provide that health insurance issuers and medical malpractice insurance issuers are subject to the antitrust laws of the United States, and for other purposes.</p><p/><center><p nid="t0:ih:6">IN THE HOUSE OF REPRESENTATIVES</p></center>
<p/><h3 nid="t0:ih:7"><center><p nid="t0:ih:8">January 3, 2013</p></center></h3>
<p nid="t0:ih:9">Mr. CONYERS introduced the following bill; which was referred to the Committee on the Judiciary</p><hr/><p/><center><p nid="t0:ih:10">A BILL</p></center>
<p nid="t0:ih:11">To prohibit anticompetitive activities and to provide that health insurance issuers and medical malpractice insurance issuers are subject to the antitrust laws of the United States, and for other purposes.</p><ul><p nid="t0:ih:12"><em>  Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,</em></p></ul><p/><h3 nid="t0:ih:13">SECTION 1. SHORT TITLE.</h3>
<ul><p nid="t0:ih:14">This Act may be cited as the &#x2018;Health Insurance Industry Antitrust Enforcement Act of 2013&#x2019;.</p></ul><p/><h3 nid="t0:ih:15">SEC. 2. PROHIBITION OF ANTICOMPETITIVE ACTIVITIES.</h3>
<ul><p nid="t0:ih:16">Notwithstanding any other provision of law, nothing in the Act of March 9, 1945 (<usc-reference title="15" section="1011" paragraph="">15 U.S.C. 1011</usc-reference> et seq., commonly known as the &#x2018;McCarran-Ferguson Act&#x2019;), shall be construed to permit health insurance issuers (as defined in section 2791 of the Public Health Service Act (<usc-reference title="42" section="300gg-91" paragraph="">42 U.S.C. 300gg-91</usc-reference>)) or issuers of medical malpractice insurance to engage in any form of price fixing, bid rigging, or market allocations in connection with the conduct of the business of providing health insurance coverage (as defined in such section) or coverage for medical malpractice claims or actions.</p></ul><p/><h3 nid="t0:ih:17">SEC. 3. RESTORING THE APPLICATION OF ANTITRUST LAWS TO HEALTH SECTOR INSURERS.</h3>
<ul><p nid="t0:ih:18">(a) Amendment to McCarran-Ferguson Act- Section 3 of the Act of March 9, 1945 (<usc-reference title="15" section="1013" paragraph="">15 U.S.C. 1013</usc-reference>), commonly known as the McCarran-Ferguson Act, is amended by adding at the end the following:</p><blockquote><p nid="t0:ih:19">&#x2018;(c) Nothing contained in this Act shall modify, impair, or supersede the operation of any of the antitrust laws with respect to the business of health insurance. For purposes of the preceding sentence, the term &#x2018;antitrust laws&#x2019; has the meaning given it in subsection (a) of the first section of the Clayton Act, except that such term includes section 5 of the Federal Trade Commission Act to the extent that such section 5 applies to unfair methods of competition.&#x2019;.</p></blockquote><p nid="t0:ih:20">(b) Related Provision- For purposes of section 5 of the Federal Trade Commission Act (<usc-reference title="15" section="45" paragraph="">15 U.S.C. 45</usc-reference>) to the extent such section applies to unfair methods of competition, section 3(c) of the McCarran-Ferguson Act shall apply with respect to the business of health insurance without regard to whether such business is carried on for profit, notwithstanding the definition of &#x2018;Corporation&#x2019; contained in section 4 of the Federal Trade Commission Act.</p></ul></body>
